Repo Dosen ULM
Post-chemotherapy response of paclitaxel and carboplatin regimens in advanced stage cervical cancer types of histopathology squamous cell carcinoma and adenocarcinoma
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | YUSERAN, ha | |
| dc.date.accessioned | 2024-09-09T03:21:39Z | |
| dc.date.available | 2024-09-09T03:21:39Z | |
| dc.date.issued | 2023-02-23 | |
| dc.identifier.issn | 2302-2914 | |
| dc.identifier.uri | https://repo-dosen.ulm.ac.id//handle/123456789/36189 | |
| dc.description.abstract | Cervical cancer incidence in South Borneo was placed 10th in Indonesia. South Borneo Department of Health revealed 1,930 patients diagnosed with cervical cancer in 2019. The main therapy for advanced cervical cancer was radiotherapy, chemotherapy, and combination. This study aims to demonstrate that paclitaxel plus carboplatin regimens have a better post-chemotherapy response in patients with advanced cervical cancer squamous cell carcinoma than adenocarcinoma. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Ba | en_US |
| dc.subject | Post-chemotherapy response, squamous cell carcinoma, adenocarcinoma | en_US |
| dc.title | Post-chemotherapy response of paclitaxel and carboplatin regimens in advanced stage cervical cancer types of histopathology squamous cell carcinoma and adenocarcinoma | en_US |
| dc.type | Article | en_US |
Files in this item
This item appears in the following Collection(s)
-
Turnitin / Peer Review / Koran / Hak Cipta / Hak Paten / Penelitian / Pengabdian [17359]
Repositori untuk bidang Turnitin / Peer Review / Koran / Hak Cipta / Hak Paten / Penelitian / Pengabdian